Cargando…
Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based study
BACKGROUND: To assess baseline characteristics, drug utilisation and healthcare use for oral anticoagulants (OACs) following the introduction of non-vitamin K antagonist oral anticoagulants among patients with atrial fibrillation in primary care in Norway. METHODS: In this retrospective longitudinal...
Autores principales: | Halvorsen, Sigrun, Smith, Jørgen Anton, Söderdahl, Fabian, Thuresson, Marcus, Solli, Oddvar, Ulvestad, Maria, Jonasson, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404608/ https://www.ncbi.nlm.nih.gov/pubmed/36008778 http://dx.doi.org/10.1186/s12875-022-01824-6 |
Ejemplares similares
-
Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation
por: Rutherford, Ole-Christian Walter, et al.
Publicado: (2022) -
A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants
por: Halvorsen, Sigrun, et al.
Publicado: (2017) -
Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study
por: Rutherford, Ole-Christian W, et al.
Publicado: (2020) -
Should we shift warfarin to non-vitamin K antagonist oral anticoagulants for patients with atrial fibrillation staying well on warfarin for years?
por: Chao, T, et al.
Publicado: (2023) -
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study
por: Halvorsen, Sigrun, et al.
Publicado: (2021)